Moderna skirts the reefs of disaster and sails into Wall Street with a $604M IPO bounty — but shares slide
Moderna just pulled off the biggest biotech IPO in the industry’s history, selling an upsized 26.2 million shares at $23 each — the mid-point on its range — and setting the bar for the next big thing at $604 million.
The offering — a boost of 20% in the number of shares sold — sets Moderna’s market cap tonight at about $7.5 billion. And with a long list of underwriters, the greenshoe has yet to drop.
Now you can expect all eyes to turn to the trading tomorrow, to see if the biotech unicorn can survive a turbulent market and watch its shares trade higher. The betting — both ways — will be huge.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 158,500+ biopharma pros reading Endpoints daily — and it's free.